Paper Details

  1. Home
  2. Paper Details

Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.

Author: EngelRolf R, HuhnMaximilian, LeuchtStefan, TardyMagdolna

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This review examined the effects of the high-potency antipsychotic fluphenazine compared to low-potency antipsychotics in schizophrenia treatment. Despite treatment guidelines stating no difference in efficacy between antipsychotic compounds, clinicians often perceive low-potency antipsychotics as less efficacious. The review found that fluphenazine was as effective as low-potency antipsychotics in controlling positive symptoms, but may be associated with a higher risk of extrapyramidal side effects.
Paper Details　
Original Abstract of the Article :
Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between any other antipsychotic compounds, however, low-potency antipsychotic drugs are often perceived as less efficacious than high-potency compounds by clinicians, and ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD009230.pub2

データ提供：米国国立医学図書館（NLM）

Fluphenazine vs. Low-Potency Antipsychotics: A Quest for Optimal Treatment

Navigating the complexities of schizophrenia can feel like wandering through a desert of confusion and uncertainty. This study examines the effectiveness of fluphenazine, a high-potency antipsychotic drug, compared to low-potency antipsychotics in treating schizophrenia. The authors note that while treatment guidelines suggest no significant difference in efficacy between different antipsychotics, clinicians often perceive low-potency drugs as less effective. This study aims to clarify this perception and evaluate the relative merits of each approach.

Finding the Right Path Through the Desert of Schizophrenia

This study highlights the need for further research to understand the nuances of antipsychotic treatment for schizophrenia, taking into account both efficacy and side effects. Finding the right path through the desert of this complex condition requires a careful balance of evidence and personalized care.

Navigating the Challenges of Schizophrenia

Schizophrenia can be a challenging condition, and finding the right treatment is crucial for improving quality of life and promoting well-being. It's essential to work closely with a mental health professional to develop a personalized treatment plan that addresses individual needs and promotes recovery.

Dr.Camel's Conclusion

This study emphasizes the need for a nuanced understanding of antipsychotic treatment for schizophrenia, taking into account both efficacy and side effects. Finding the optimal path through the desert of this condition requires a careful balance of evidence-based practices and personalized care, ensuring that individuals receive the support they need to navigate this complex journey.
Date :
  1. Date Completed 2014-09-19
  2. Date Revised 2022-01-29
Further Info :

Pubmed ID

25087165

DOI: Digital Object Identifier

10.1002/14651858.CD009230.pub2

Related Literature

Article Analysis
・Side Effects of fluphenazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.